Xenoglim-MP1 Tablet ER: A Combination Therapy for Blood Sugar Control

Xenoglim-MP1 Tablet ER combines the efficacy of three key medications - Glimepiride, Metformin, and Pioglitazone – for optimal blood sugar control in adults with Type 2 Diabetes Mellitus. Each tablet delivers a precisely measured dose of:

* Glimepiride (1mg): A sulfonylurea medication that stimulates insulin release from the pancreas to lower blood glucose levels.
* Metformin (500mg): A biguanide medication that reduces hepatic glucose production and improves insulin sensitivity, contributing to blood sugar control.
* Pioglitazone (15mg): A thiazolidinedione medication that acts by increasing peripheral tissue glucose uptake and decreasing gluconeogenesis.

This combination offers a powerful and versatile approach for managing Type 2 Diabetes Mellitus with its comprehensive effect on multiple pathways of glucose metabolism. The extended-release formula provides consistent blood sugar management throughout the day, minimizing fluctuations and improving patient compliance.

Note: This information is intended for informational purposes only. Always consult your healthcare professional before taking any medication, including Xenoglim-MP1.